niceritrol has been researched along with Elevated Cholesterol in 5 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-three consecutive unselected patients with primary hypercholesterolemia received niceritrol 1." | 9.07 | Effects of niceritrol on levels of serum lipids, lipoprotein(a), and fibrinogen in patients with primary hypercholesterolemia. ( Arakawa, K; Handa, K; Hidaka, K; Matsunaga, A; Mori, T; Moriyama, K; Sasaki, J; Yuki, M, 1992) |
| "Effects of a combination therapy of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on lipid metabolism were investigated measuring a wide range of parameters in 42 patients with primary hypercholesterolemia." | 5.08 | Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients. ( Arakawa, K; Kobori, S; Kono, S; Matsunaga, A; Sakai, T; Sasaki, J; Sato, Y; Setoguchi, Y; Shichiri, M; Yamamoto, K, 1995) |
| "Thirty-three consecutive unselected patients with primary hypercholesterolemia received niceritrol 1." | 5.07 | Effects of niceritrol on levels of serum lipids, lipoprotein(a), and fibrinogen in patients with primary hypercholesterolemia. ( Arakawa, K; Handa, K; Hidaka, K; Matsunaga, A; Mori, T; Moriyama, K; Sasaki, J; Yuki, M, 1992) |
| "Niceritrol was started at a dose of 750 mg/day and this was increased at weekly intervals over 4 weeks to the maximum tolerated dosage up to 3 g/day." | 2.66 | Clinical and laboratory responses to niceritrol in the treatment of hypercholesterolaemia. ( Betteridge, DJ; Curtis, LD; Reckless, JP; Winder, AF, 1988) |
| "Prophylactic treatment of the hyperlipoproteinemia with the drugs niceritrol (Perycit) and beta-pyridylcarbinol (Ronicol) significantly reduced the elevated plasma cholesterol level and reduced the degree of atherosclerosis in the abdominal aorta and the coronary arteries." | 1.27 | [Experimental hyperlipoproteinemia and arteriosclerosis in minipigs--effect of various drugs]. ( Jacobsson, L, 1986) |
| " Nicotinic acid in the form of niceritrol had another type of dose-response in type II with doses from 3 to 6 g/day." | 1.25 | Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia. ( Carlson, LA; Olsson, AG; Orö, L; Rössner, S, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sasaki, J | 2 |
| Yamamoto, K | 1 |
| Kobori, S | 1 |
| Setoguchi, Y | 1 |
| Sato, Y | 1 |
| Matsunaga, A | 2 |
| Shichiri, M | 1 |
| Sakai, T | 1 |
| Kono, S | 1 |
| Arakawa, K | 2 |
| Orö, L | 1 |
| Olsson, AG | 1 |
| Rössner, S | 1 |
| Carlson, LA | 1 |
| Handa, K | 1 |
| Mori, T | 1 |
| Moriyama, K | 1 |
| Hidaka, K | 1 |
| Yuki, M | 1 |
| Curtis, LD | 1 |
| Reckless, JP | 1 |
| Winder, AF | 1 |
| Betteridge, DJ | 1 |
| Jacobsson, L | 1 |
3 trials available for niceritrol and Elevated Cholesterol
| Article | Year |
|---|---|
Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients.
Topics: Anticholesteremic Agents; Apolipoproteins; Cholesterol; Cholesterol Esters; Cholesterol, HDL; Fatty | 1995 |
Effects of niceritrol on levels of serum lipids, lipoprotein(a), and fibrinogen in patients with primary hypercholesterolemia.
Topics: Adult; Aged; Apolipoproteins; Apolipoproteins E; Carrier Proteins; Cholesterol; Cholesterol Ester Tr | 1992 |
Clinical and laboratory responses to niceritrol in the treatment of hypercholesterolaemia.
Topics: Adolescent; Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Administration Schedu | 1988 |
2 other studies available for niceritrol and Elevated Cholesterol
| Article | Year |
|---|---|
Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Topics: Cholestyramine Resin; Clofibrate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Human | 1975 |
[Experimental hyperlipoproteinemia and arteriosclerosis in minipigs--effect of various drugs].
Topics: Animals; Arteries; Arteriosclerosis; Cholesterol; Hypercholesterolemia; Hyperlipoproteinemias; Hypol | 1986 |